Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07495852 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study title shortened, about 2 wordsv2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Trial Details
NCT Number NCT07495852
Lead Sponsor Glaukos Corporation
Conditions
(from sponsor)		 Glaucoma
Related terms Glaucoma, Glaucoma, Open-Angle, Ocular Hypertension
Enrollment 510 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov